Showing results (11-20 of 298) with videos related to

Sort By:
Pageof 30
European Journal of Heart Failure|February 19, 2005
Diagnosis and assessment of the heart failure patient: the cornerstone of effective managementKenneth Dickstein
European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.
Swiss Medical Weekly|August 25, 2018
Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in SwitzerlandIvan Zeljkovic, Haran Burri, Alexander Breitenstein, et al.
Cardiology Research and Practice|December 1, 2018
Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter RegistrySandro Brusich, Ivan Zeljković, Nikola Pavlovic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 25, 2020
Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey IICamilla Normand, Cecilia Linde, Carina Blomström-Lundqvist, et al.
Lancet (London, England)|September 21, 2002
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanKenneth Dickstein, John Kjekshus,
European Heart Journal. Digital Health|September 25, 2024
Machine learning-based prediction of 1-year all-cause mortality in patients undergoing CRT implantation: validation of the SEMMELWEIS-CRT score in the European CRT Survey I datasetMárton Tokodi, Annamária Kosztin, Attila Kovács, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trialVernon VS Bonarjee, Kenneth Dickstein
JACC. Clinical Electrophysiology|September 21, 2019
Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 PatientsAngelo Auricchio, Maurizio Gasparini, Cecilia Linde, et al.
Acta Cardiologica|June 14, 2019
Benchmarking Belgian CRT practice against the rest of Europe: insights from the ESC-CRT survey IIAnaïs Gauthey, Rik Willems, Yves Vandekerckhove, et al.
Pageof 30